Max Hodak, co-founder and CEO of Science Corporation, joins Sarah Guo to discuss the future of vision, brain-computer interfaces, and the human experience. Max explains how Science’s PRIMA retinal implant could restore functional vision for people who have lost their sight, and why treating the brain as a computational system could unlock new approaches to medicine. They explore the broader potential of neural devices, from restoring lost capabilities to expanding human potential, as well as deeper questions around identity, consciousness, and whether the human experience can persist as our biological hardware changes. Max also shares Science’s long-term vision for reducing the fragility of the human condition by repairing, replacing, and ultimately upgrading parts of ourselves. Finally, he discusses the surprising parallels between AI models and biological brains, and why AI may offer a powerful new lens for understanding intelligence. Chapters: 00:00 – Cold Open Trailer 01:40 – Max Hodak Introduction 02:00 – Science Corporation Overview and Origin 02:53 – A Revolutionary Solve for Blindness  06:32 – Scope of Timeline and Engineer Cost 09:10 – Clinic Trial Process 09:45 - The Response from Clinicians 12:21 – Broader Biotech Landscape 14:59 – Brain’s Relationship to Senses 17:35 – The Study of Consciousness  19:50 – Investments in Brain Computer Interface 22:10 – Fertile Ways to Study Neuroscience 24:46 – Biotech Expansion for Science Corporation 27:50 – What Success Looks Like in Neuroscience and Tech 29:06 - Goals Within Human Preservation vs. Adaptation  30:25 – Conclusion